GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

Symbol: AMLX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$26,163,536	2,165,534	+353,495	+20%	$12.08	Q4 2025
30 Sep 2025	0%	+0%	$24,631,001	1,812,039	+119,626	+7.1%	$13.59	Q3 2025
30 Jun 2025	0%	+0%	$10,850,718	1,692,413	+886,252	+110%	$6.41	Q2 2025
31 Mar 2025	0%	+0%	$2,854,903	806,161	+238,258		$3.54	Q1 2025
31 Dec 2024	0%	+0%	$2,147,837	567,903	+16,864	+3.1%	$3.78	Q4 2024
30 Sep 2024	0%	+0%	$1,785,770	551,039	+82,173	+18%	$3.24	Q3 2024
30 Jun 2024	0%	-0%	$891,092	468,866	-597,379	-56%	$1.90	Q2 2024
31 Mar 2024	0%	+0%	$3,028,492	1,066,245	+35,529	+3.4%	$2.84	Q1 2024
31 Dec 2023	0%	+0%	$15,173,546	1,030,716	+48,648	+5%	$14.72	Q4 2023
30 Sep 2023	0%	+0%	$17,983,593	982,068	+44,071	+4.7%	$18.31	Q3 2023
30 Jun 2023	0%	+0%	$20,232,602	937,997	+47,015	+5.3%	$21.57	Q2 2023
31 Mar 2023	0%	+0%	$26,141,422	890,982	+37,069	+4.3%	$29.34	Q1 2023
31 Dec 2022	0%	+0%	$31,552,000	853,913	+218,357	+34%	$36.95	Q4 2022
30 Sep 2022	0%	+0%	$17,890,000	635,556	+404,139	+175%	$28.15	Q3 2022
30 Jun 2022	0%	+0%	$4,457,000	231,417	+41,267	+22%	$19.26	Q2 2022
31 Mar 2022	0%	+0%	$2,443,000	190,150	+190,150	NEW	$12.85	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.